01
Human biology
Brain Organoids
A new generation of human brain models designed to generate biologically relevant insights and support therapeutic discovery in neurodegenerative diseases.
Helios Neopharma
Pioneering precision medicine for the adult brain
Brain Organoids • Artificial Intelligence • Precision Neurology
Discover our platformScroll to explore
The challenge
Neurodegenerative diseases are among the greatest challenges of the 21st century.
Despite decades of research and billions invested worldwide, finding effective therapies remains exceptionally difficult.
A major obstacle is the lack of human-relevant models that sufficiently reproduce the complexity of brain biology. This limits our ability to identify promising treatments and to predict which discoveries will truly translate to patients.
Alzheimer’s disease · Parkinson’s disease · ALS · Huntington’s disease
About the company
Building a new foundation for precision neurology.
Helios Neopharma develops next-generation technologies combining brain organoids, biological data and artificial intelligence to accelerate therapeutic discovery for neurodegenerative diseases.
Our ambition is to help bridge the gap between laboratory research and treatments that can make a meaningful difference for patients.
Better human models.
Better therapeutic discovery.
Better outcomes for patients.
Better therapeutic discovery.
Better outcomes for patients.
Our platform
From human biology to therapeutic insight.
Brain organoids, biological data and artificial intelligence brought together to support the discovery of more effective therapies.
02
Biological intelligence
Biological Data
Integrating complex biological signals to reveal patterns, deepen disease understanding and support better therapeutic decisions.
03
Computational intelligence
Artificial Intelligence
Transforming complex biological information into actionable insight to improve therapeutic discovery and translation.
Our team
Scientific excellence, united by one mission.
A multidisciplinary team rooted in neuroscience, systems biology, organoids and translational research.
01
Dr. Yousra Laouarem
CEO & Founder
Neuroscientist and entrepreneur, Yousra founded Helios Neopharma to build human-relevant technologies for precision neurology and therapeutic discovery.
in LinkedIn02
Prof. Alain Buisson
Head of Neuroscience
Internationally recognized neuroscientist specializing in Alzheimer’s disease, neurodegeneration and translational brain research.
in LinkedIn03
Dr. Alessia Polito
Principal Systems Biologist
Systems biologist with expertise in 3D cortical organoids, multi-omics, electrophysiology and advanced cellular models.
in LinkedIn04
Dr. Maya Moubarak
Neuroscientist
Neuroscientist specializing in brain organoids, stem-cell culture, omics and translational neuroscience.
in LinkedIn05
Nour Chakroun Lamiri
PhD Researcher
PhD researcher working at the intersection of bioengineering, neuroscience and next-generation human brain models.
in LinkedInOur ecosystem
Our vision
Accelerating the discovery of tomorrow’s brain therapies.
We believe the future of precision neurology will emerge from the convergence of human biology, artificial intelligence and scientific excellence.
Start a conversation